These include Wegovy, Oral Wegovy, Zepbound, and Foundayo, all of which use GLP-1 science tailored for weight loss rather than diabetes management
Therapeutic peptides as cytolytic agent in breast cancer cells Cytolytic peptides (530 AAs) have amphiphilic and cationic characteristics, allowing them to penetrate cell membranes and kill cells
Once NRF2 is ubiquitinated, it is transported to the proteasome, where it is degraded and its components recycled
The cellular basis of NIHL has opened up new avenues for protection through prophylactic compounds such as antioxidants
10.1016/j.neuropharm.2014.06.026 [DOI] [PubMed] [Google Scholar] Leonard B
Cardiovascular and kidney outcomes In patients with diabetes, GLP-1s are now FDA-approved to reduce major adverse cardiac events (MACE) and slow chronic kidney disease progression